Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Smid

Showing results (71-80 of 128) with videos related to

Pageof 13
Sort By:
Molecular Oncology|September 12, 2021
A panel of DNA methylation markers for the classification of consensus molecular subtypes 2 and 3 in patients with colorectal cancerInge van den Berg, Marcel Smid, Robert R J Coebergh van den Braak, et al.
Science Translational Medicine|January 25, 2013
KLF6-SV1 drives breast cancer metastasis and is associated with poor survivalRaheleh Hatami, Anieta M Sieuwerts, Sudeh Izadmehr, et al.
NPJ Breast Cancer|July 14, 2023
Tumor-agnostic ctDNA levels by mFAST-SeqS in first-line HR-positive, HER2 negative metastatic breast cancer patients as a biomarker for survivalNoortje Verschoor, Vanja de Weerd, Mai N Van, et al.
Scientific Reports|July 28, 2022
HER2-low breast cancer shows a lower immune response compared to HER2-negative casesNadine S van den Ende, Marcel Smid, Annemieke Timmermans, et al.
The EMBO Journal|October 28, 2005
Transcriptome analysis reveals cyclobutane pyrimidine dimers as a major source of UV-induced DNA breaksGeorge A Garinis, James R Mitchell, Michael J Moorhouse, et al.
Scientific Reports|May 20, 2017
Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancerTommaso De Marchi, Mieke A Timmermans, Anieta M Sieuwerts, et al.
Plos One|May 8, 2019
MicroRNAs as possible indicators of drug sensitivity in breast cancer cell linesKatharina Uhr, Wendy J C Prager-van der Smissen, Anouk A J Heine, et al.
Cancer Letters|December 29, 2011
CD49f-based selection of circulating tumor cells (CTCs) improves detection across breast cancer subtypesBianca Mostert, Jaco Kraan, Anieta M Sieuwerts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2008
Gene expression profiles associated with the presence of a fibrotic focus and the growth pattern in lymph node-negative breast cancerGert G Van den Eynden, Marcel Smid, Steven J Van Laere, et al.
Journal of Proteome Research|January 23, 2015
Integrative analysis of genomics and proteomics data on clinical breast cancer tissue specimens extracted with acid guanidinium thiocyanate-phenol-chloroformRené B H Braakman, Karel Bezstarosti, Anieta M Sieuwerts, et al.
Pageof 13

Showing results (71-80 of 128) with videos related to

Sort By:
Pageof 13
Molecular Oncology|September 12, 2021
A panel of DNA methylation markers for the classification of consensus molecular subtypes 2 and 3 in patients with colorectal cancerInge van den Berg, Marcel Smid, Robert R J Coebergh van den Braak, et al.
Science Translational Medicine|January 25, 2013
KLF6-SV1 drives breast cancer metastasis and is associated with poor survivalRaheleh Hatami, Anieta M Sieuwerts, Sudeh Izadmehr, et al.
NPJ Breast Cancer|July 14, 2023
Tumor-agnostic ctDNA levels by mFAST-SeqS in first-line HR-positive, HER2 negative metastatic breast cancer patients as a biomarker for survivalNoortje Verschoor, Vanja de Weerd, Mai N Van, et al.
Scientific Reports|July 28, 2022
HER2-low breast cancer shows a lower immune response compared to HER2-negative casesNadine S van den Ende, Marcel Smid, Annemieke Timmermans, et al.
The EMBO Journal|October 28, 2005
Transcriptome analysis reveals cyclobutane pyrimidine dimers as a major source of UV-induced DNA breaksGeorge A Garinis, James R Mitchell, Michael J Moorhouse, et al.
Scientific Reports|May 20, 2017
Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancerTommaso De Marchi, Mieke A Timmermans, Anieta M Sieuwerts, et al.
Plos One|May 8, 2019
MicroRNAs as possible indicators of drug sensitivity in breast cancer cell linesKatharina Uhr, Wendy J C Prager-van der Smissen, Anouk A J Heine, et al.
Cancer Letters|December 29, 2011
CD49f-based selection of circulating tumor cells (CTCs) improves detection across breast cancer subtypesBianca Mostert, Jaco Kraan, Anieta M Sieuwerts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2008
Gene expression profiles associated with the presence of a fibrotic focus and the growth pattern in lymph node-negative breast cancerGert G Van den Eynden, Marcel Smid, Steven J Van Laere, et al.
Journal of Proteome Research|January 23, 2015
Integrative analysis of genomics and proteomics data on clinical breast cancer tissue specimens extracted with acid guanidinium thiocyanate-phenol-chloroformRené B H Braakman, Karel Bezstarosti, Anieta M Sieuwerts, et al.
Pageof 13